Send to

Choose Destination
Eur J Pharmacol. 1985 Dec 3;118(3):367-70.

[3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors.


Chronic treatment with SCH 23390, a selective D-1 dopamine receptor antagonist, increased (40%) the density of [3H]SCH 23390 binding sites in striatal membrane preparations but failed to change the apparent KD of the ligand for its binding sites. Haloperidol, which preferentially blocks D-2 receptors, induced only a slight, not significant increase in the total number of [3H]SCH 23390 binding sites. (-)Sulpiride, a selective D-2 receptor blocker, also failed to change either Bmax or KD of [3H]SCH 23390 binding. Thus, chronic blockade of D-1 receptor sites by SCH 23390 can lead to an increase in their total number.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center